It looks like you are using an older version of Internet Explorer which is not supported. We advise that you update your browser to the latest version of Microsoft Edge, or consider using other browsers such as Chrome, Firefox or Safari.

Verify payer-specific coding requirements. For reimbursement information, please contact Sandoz One Source.

Zarxio billing and coding information

Learn about ZIEXTENZO (pegfilgrastim-bmez), the long-acting G-CSF treatment option from Sandoz2

G-CSF=granulocyte colony-stimulating factor.

References: 1. ZARXIO Prescribing Information. Sandoz Inc. September 2022. 2. ZIEXTENZO Prescribing Information. Sandoz Inc. March 2021.